Catherine Berens, Policy Officer at the European Commission presented within the Market Access, Pricing & Reimbursement track at the 2012 World Orphan Drug Congress in Geneva. With a focus to providing uniform access to medicines in Europe, the Working group Mechanism of coordinated access to orphan medicinal products (MoCA-OMP) has an aim to find innovative ways to provide real access to orphan drug for patients with unmet medical needs, for whom these solutions would otherwise be out of reach, in an affordable and sustainable way.
You can freely download Catherine Beren’s presentation slides here
The 4th Annual World Orphan Drug Congress in Geneva is Europe’s leading commercially-focused orphan drug event bringing together industry, patient groups, payers and academia. Download the event prospectus for more information.
For more updates on Pharma, biotech and R&D, follow us on Twitter: @biopharmaevents or join our LinkedIn group: BioPharma- Networking for Pharmaceuticals, Biotech and R&D